Blood Cells, Red

Summary

Blood Cells, Red (CHEMBL2108195) is a phase-3 clinical-stage unknown; indicated across 5 conditions including injury and anemia.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Unknown
• Indications: 5 conditions
• Clinical trials: 6

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2108195
Name	Blood Cells, Red
Type	Unknown
Max phase	3

Also known as: Blood cells, red, Hematocrit, Human red blood cells, Red blood cells, BLOOD CELLS, RED

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

5 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
injury	3	MONDO:0021178	EFO:0000546
anemia	3	MONDO:0002280	EFO:0004272
beta thalassemia	3	MONDO:0019402	MONDO:0016486
cardiovascular disorder	2	MONDO:0004995	EFO:0000319
sickle cell disease	1	MONDO:0011382	MONDO:0011382

Clinical trials

Total trials: 6.

Phase distribution

Phase	Trials
Not specified	4
PHASE3	1
EARLY_PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04704869	PHASE3	COMPLETED	Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
NCT04814264	EARLY_PHASE1	COMPLETED	Pilot Study of Sex-matched vs. Sex-mismatched Red Blood Cell Transfusion
NCT02784951	Not specified	COMPLETED	Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System
NCT02953483	Not specified	UNKNOWN	Ex Vivo Lung Perfusion : Effect of Cellular Perfusate on Mechanical Properties and Gas Exchange Function of Donor Lungs
NCT03784794	Not specified	COMPLETED	Patient Blood Management for Massive Obstetric Hemorrhage
NCT05118048	Not specified	TERMINATED	StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).